![Tiffany Inglis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 174 651 $ al 30/09/2026
Dr. Tiffany Inglis, MD, is a Chief Medical Officer at Sera Prognostics, Inc. She received her doctorate degree from the University of Toledo Medical Center.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 12/10/2026 | 83.565 ( 0,22 % ) | 174 651 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SERA PROGNOSTICS, INC. | Director Técnico/Científico/I+D | 01/10/2025 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
University of Toledo Medical Center
 University of Toledo Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sera Prognostics, Inc.
 Sera Prognostics, Inc. Medical/Nursing ServicesHealth Services Provides personalized diagnostics to predict and manage pregnancy complications | Health Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
